Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in IntangiblesChange in InventoryGains from Investment SecuritiesNet Debt Issuances and RepaymentsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Share-based Compensation: 2022-2023

Historic Share-based Compensation for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to $818,991.

  • Mainz Biomed N.V's Share-based Compensation fell 47.39% to $818,991 in Q4 2023 from the same period last year, while for Dec 2023 it was $4.0 million, marking a year-over-year decrease of 59.23%. This contributed to the annual value of $1.1 million for FY2024, which is 71.63% down from last year.
  • As of Q4 2023, Mainz Biomed N.V's Share-based Compensation stood at $818,991, which was down 24.88% from $1.1 million recorded in Q3 2023.
  • In the past 5 years, Mainz Biomed N.V's Share-based Compensation registered a high of $2.9 million during Q1 2022, and its lowest value of $818,991 during Q4 2023.
  • Its 2-year average for Share-based Compensation is $1.7 million, with a median of $1.4 million in 2022.
  • Data for Mainz Biomed N.V's Share-based Compensation shows a maximum YoY crashed of 67.89% (in 2023) over the last 5 years.
  • Mainz Biomed N.V's Share-based Compensation (Quarterly) stood at $1.6 million in 2022, then crashed by 47.39% to $818,991 in 2023.
  • Its Share-based Compensation stands at $818,991 for Q4 2023, versus $1.1 million for Q3 2023 and $1.2 million for Q2 2023.